Analysis of Candida auris fungemia at a single facility in Kenya
| Autor: | Gunturu Revathi, Michael A. Pfaller, Nancy Okinda, Jasmit Shah, Elizabeth Kagotho, Rodney D. Adam, Daniel Maina, Mariana Castanheira, Melanie Fontaine |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
0301 basic medicine
Microbiology (medical) Adult Male medicine.medical_specialty Antifungal Agents 030106 microbiology Human pathogen lcsh:Infectious and parasitic diseases 03 medical and health sciences Young Adult 0302 clinical medicine Risk Factors Internal medicine Candida albicans Medicine Antimicrobial stewardship Humans lcsh:RC109-216 030212 general & internal medicine Single institution Fungemia Aged Candida business.industry Electronic medical record Candidemia General Medicine Middle Aged medicine.disease Antimicrobial Kenya Corpus albicans Infectious Diseases Candida auris Female business |
| Zdroj: | International Journal of Infectious Diseases, Vol 85, Iss, Pp 182-187 (2019) |
| ISSN: | 1878-3511 |
| Popis: | Objectives: Candida auris emerged as a human pathogen in 2009 and has subsequently been identified around the world as a cause of invasive candidiasis. We did an analysis from a single institution in order to analyze risk factors and outcomes for C. auris candidemia. Methods: Patients with candidemia were identified by the electronic medical record and reviewed for risk factors and outcome. Candida isolates were identified by Vitek2 as Candida haemulonii, but species determinations for 21 of the isolates using published molecular and proteomic methods identified all as C. auris. Findings: From September 2010 to December 2016, C. auris accounted for 38% of 201 patients with candidemia, while C. albicans contributed 25%. C. auris patients had been hospitalized longer (mean 32 days vs. 13 days; p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|